23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...

Genetic testing firm 23andMe said today it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring program.